…
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Precision Optics Corporation (POCI) is a Nasdaq-listed company; publicly available disclosures are limited, preventing a detailed, verifiable description of its operations or product lines. Long-term growth drivers are not clearly documented; investors may benefit if the company clarifies strategy and demonstrates execution, but prospects hinge on improved transparency and operational progress.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Income before tax | -0.14M | -0.93M | -0.10M | -1.42M | -0.61M |
| Net income | -0.14M | -0.93M | -0.10M | -1.43M | -0.61M |
| Selling general administrative | 7.38M | 5.61M | 3.71M | 3.90M | 2.10M |
| Gross profit | 7.73M | 4.93M | 3.43M | 3.36M | 2.12M |
| Reconciled depreciation | 0.21M | 0.19M | 0.15M | 0.11M | 0.04M |
| Ebit | -0.64M | -1.35M | -0.91M | -1.42M | -0.48M |
| Ebitda | -0.43M | -1.16M | -0.76M | -1.31M | -0.45M |
| Depreciation and amortization | 0.21M | 0.19M | 0.15M | 0.11M | 0.04M |
| Operating income | -0.64M | -1.35M | -0.91M | -1.42M | -0.48M |
| Other operating expenses | 21.68M | 17.03M | 11.58M | 11.35M | 7.29M |
| Interest expense | 0.22M | 0.16M | 0.01M | 0.00M | 0.00M |
| Tax provision | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Net interest income | -0.22M | -0.16M | -0.01M | -0.00M | -0.00M |
| Income tax expense | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Total revenue | 21.04M | 15.68M | 10.67M | 9.92M | 6.80M |
| Total operating expenses | 8.37M | 6.28M | 4.34M | 4.79M | 2.61M |
| Cost of revenue | 13.31M | 10.75M | 7.24M | 6.56M | 4.68M |
| Total other income expense net | 0.71M | 0.42M | 0.80M | -0.00M | -0.13M |
| Net income from continuing ops | -0.14M | -0.93M | -0.10M | -1.43M | -0.61M |
| Net income applicable to common shares | -0.14M | -0.93M | -0.10M | -1.43M | -0.61M |
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Total assets | 19.74M | 16.70M | 6.26M | 6.35M | 7.49M |
| Intangible assets | 0.27M | 0.23M | 0.14M | 0.10M | 0.05M |
| Other current assets | 0.25M | 0.21M | 0.15M | 0.13M | 0.18M |
| Total liab | 7.69M | 7.73M | 2.83M | 3.58M | 4.12M |
| Total stockholder equity | 12.05M | 8.97M | 3.43M | 2.77M | 3.38M |
| Other current liab | 0.93M | 0.88M | 0.76M | 0.75M | 1.98M |
| Common stock | 0.06M | 0.17M | 0.13M | 0.13M | 0.12M |
| Capital stock | 0.06M | 0.17M | 0.13M | 0.13M | 0.12M |
| Retained earnings | -48.24M | -48.09M | -47.17M | -47.06M | -45.64M |
| Other liab | - | 0.71M | 0.17M | 0.33M | 0.50M |
| Good will | 8.82M | 8.82M | 0.69M | 0.69M | 0.69M |
| Cash | 2.93M | 0.61M | 0.86M | 1.13M | 2.29M |
| Total current liabilities | 5.26M | 4.59M | 2.51M | 3.15M | 3.61M |
| Current deferred revenue | 1.17M | 0.91M | 0.45M | 0.42M | 0.45M |
| Net debt | 0.23M | 2.39M | -0.61M | -0.12M | -2.27M |
| Short term debt | 0.73M | 0.56M | 0.10M | 0.92M | 0.01M |
| Short long term debt | 0.51M | 0.37M | - | 0.81M | - |
| Short long term debt total | 3.16M | 3.00M | 0.25M | 1.01M | 0.01M |
| Other stockholder equity | 60.22M | 56.90M | 50.46M | 49.70M | 48.89M |
| Property plant equipment | 0.79M | 1.15M | 0.66M | 0.62M | 0.38M |
| Total current assets | 9.86M | 6.51M | 4.78M | 4.95M | 6.37M |
| Net tangible assets | 2.96M | -0.08M | 2.60M | 1.99M | 2.64M |
| Net receivables | 3.91M | 2.66M | 1.88M | 1.48M | 2.17M |
| Long term debt | 2.18M | 1.96M | - | - | - |
| Inventory | 2.78M | 3.02M | 1.89M | 2.20M | 1.73M |
| Accounts payable | 2.43M | 2.24M | 1.21M | 1.07M | 1.17M |
| Non currrent assets other | -3.60M | - | - | - | - |
| Non current assets total | 9.88M | 10.20M | 1.48M | 1.40M | 1.12M |
| Capital lease obligations | 0.47M | 0.67M | 0.25M | 0.21M | 0.01M |
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Investments | -0.05M | -0.41M | -0.29M | -1.60M | -0.04M |
| Change to liabilities | 0.46M | 0.45M | 0.17M | -0.14M | -0.36M |
| Total cashflows from investing activities | -0.05M | -0.41M | -0.12M | -1.60M | -0.04M |
| Net borrowings | 0.34M | -0.29M | -0.06M | 0.77M | -0.01M |
| Total cash from financing activities | 2.45M | 1.09M | -0.03M | 1.04M | 2.96M |
| Change to operating activities | 0.17M | -0.08M | -0.01M | 0.09M | 0.01M |
| Net income | -0.14M | -0.93M | -0.10M | -1.43M | -0.61M |
| Change in cash | 2.32M | -0.26M | -0.27M | -1.15M | 1.89M |
| Begin period cash flow | 0.61M | 0.86M | 1.13M | 2.29M | 0.40M |
| End period cash flow | 2.93M | 0.61M | 0.86M | 1.13M | 2.29M |
| Total cash from operating activities | -0.08M | -0.93M | 0.05M | -0.59M | -1.03M |
| Issuance of capital stock | 2.29M | 1.50M | 0.24M | 0.27M | 2.92M |
| Depreciation | 0.21M | 0.19M | 0.15M | 0.11M | 0.04M |
| Change to inventory | 0.25M | -0.68M | 0.31M | -0.46M | 0.14M |
| Change to account receivables | -1.24M | -0.11M | -0.40M | 0.68M | -0.72M |
| Other cashflows from financing activities | 0.57M | -0.13M | -0.17M | 0.82M | 0.04M |
| Change to netincome | 0.22M | 0.23M | -0.08M | 0.55M | 0.48M |
| Capital expenditures | 0.05M | 0.15M | 0.12M | 0.16M | 0.15M |
| Change in working capital | -0.36M | -0.42M | 0.07M | 0.17M | -0.94M |
| Stock based compensation | 0.92M | 0.92M | 0.73M | 0.50M | 0.47M |
| Other non cash items | -0.70M | -0.69M | -0.81M | 0.04M | 0.01M |
| Free cash flow | -0.13M | -1.09M | -0.08M | -0.75M | -1.18M |
Sector: Healthcare Industry: Medical Instruments & Supplies
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| POCI Precision Optics Corporation, Inc. Common stock |
0.02 0.40% |
5.07 | - | - | 1.72 | 2.93 | 1.82 | -27.04 |
| ISRG Intuitive Surgical Inc |
-8.88 1.97% |
440.65 | 43.30 | 31.35 | 12.25 | 7.35 | 11.63 | 30.22 |
| ESLOF EssilorLuxottica Société anonyme |
-2.56 1.26% |
200.18 | 44.84 | 27.62 | 4.07 | 2.49 | 3.71 | 16.04 |
| ESLOY Essilor International SA |
-1.98 1.94% |
99.87 | 41.68 | 27.25 | 3.94 | 2.45 | 3.71 | 16.04 |
| BDX Becton Dickinson and Company |
0.83 0.39% |
215.35 | 31.62 | 13.76 | 2.25 | 2.04 | 2.93 | 13.40 |
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.
| Name | Title | Year Born |
|---|---|---|
| Dr. Joseph N. Forkey | CEO, Pres, Treasurer & Director | 1968 |
| Mr. Daniel S. Habhegger | CFO & Company Sec. | 1970 |
| Mr. Jeffrey L. DiRubio | Sr. VP of Sales & Marketing | NA |
| Mr. Richard E. Forkey | Founder, Advisor to the CEO & Director Emeritus | 1940 |
| Mr. John Hargraves | Director of Operations | NA |
| Mr. Bruce Radl | Director of Technology Devel. | NA |
| Mr. Donald A. Major | Consultant | 1961 |
| Mr. Divaker Mangadu | Pres of Ross Optical Division | NA |
| Mr. Richard G. Cyr | Optics Laboratory Mang. | NA |
| Dr. Joseph N. Forkey | CEO, President, Treasurer & Director | 1968 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.